To Evaluate the Clinical Safety and Efficacy of Limbal Stem Cell for Treatment of Superficial Corneal Pathologies".

NCT04932629 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Corneal Scars and Opacities

Interventions

BIOLOGICAL: Ex-vivo cultivated Allogeneic limbal stromal stem cells

Sponsor

L.V. Prasad Eye Institute